Mitchell Cahn, MD
Vascular Surgery · Sunnyside, WANPI 1164461331
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,069 of the $1,476 with a category attached, or 72.4%. 8 manufacturers reported payments, led by Stryker at 45.5% of the total. 2025 is the largest year on record at $716, 8.9 times the $80 reported in 2019. That places this record below the midpoint for vascular surgery clinicians in WA, where the typical reported total is $4,221.
Across 19 payments — averaging $77.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$672
- Globus Medical$382
- Philips North America LLC$158
- Johnson & Johnson$126
- Inari Medical, Inc.$72
- Medtronic$34
- plus $32 from 2 others
What the payments were for
- Travel & lodging$36225%
- Food & beverage$1,06972%
- Education$463%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 8 | $672 |
| Globus Medical | 2 | $382 |
| Philips North America LLC | 2 | $158 |
| Johnson & Johnson | 2 | $126 |
| Inari Medical, Inc. | 2 | $72 |
| Medtronic | 1 | $34 |
| Cook Medical LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RISE-L$362
- FlowTriever$164
- CLOTTRIEVER BOLD CATHETER$117
- ARTIX MT$101
How this compares
$1,476 in reported general payments places this provider in the 30th percentile of 111 vascular surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 19 | $40 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Sunnyside
- Benjamin StarnesSeatle$666K
- Kathleen GibsonBellevue$593K
- Brian FerrisBellevue$170K
- Sara ZettervallSeattle$126K
- Paul HayesSeattle$83K
- Elina QuirogaSeattle$69K
- Lorena de Marco GarciaYakima$60K
- Mark MeissnerSeattle$43K
- Stephen MurraySpokane$38K
- Niten SinghSeattle$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.